Astellas Pharma
4503.T
$9.58
Share price
1.02%
Change (1 day)
-36.13%
Change (1 year)
Categories
P/S ratio for Astellas Pharma (4503.T)
P/S ratio as of April 2024 (TTM): 1.56
According to Astellas Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.56405. At the end of 2023 the company had a P/S ratio of 1.98.
P/S ratio history for Astellas Pharma from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.98 | -20.71% |
| 2022 | 2.49 | -3.83% |
| 2021 | 2.59 | 6.74% |
| 2020 | 2.43 | -10.37% |
| 2019 | 2.71 | 31.45% |
| 2018 | 2.06 | -6.64% |
| 2017 | 2.21 | -6.57% |
| 2016 | 2.36 | -14.06% |
| 2015 | 2.75 | -1.98% |
| 2014 | 2.81 | 21.62% |
| 2013 | 2.31 | 30.32% |
| 2012 | 1.77 | 18.14% |
| 2011 | 1.50 | -5.51% |
| 2010 | 1.59 | -12.13% |
| 2009 | 1.80 |